Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-01 @ 4:03 AM
Study NCT ID:
NCT00352859
Status:
TERMINATED
Last Update Posted:
2014-12-30
First Post:
2006-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
12178
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None